Angiograms at 2.4±1 hours after thrombolytic therapy showed reperfusion (TIMI grade >2) in 75% of patients. QT was measured in 10±2 leads at 9±5 days after AMI by using a computerized analysis program interfaced with a digitizer. QTd, QRSd, JT (QT minus QRS), and JT dispersion (JTd, equals maximal minus minimal JT interval) were calculated with a computer. There were significant differences in QTd (96±31, 88±25, 60±22, and 52+19 milliseconds; P<.0001) and in JTd (97±32, 88±31, 63±23, and 58±21 milliseconds; P=.0001) but not in QRSd (25±10, 22±7, 28±9, and 24±9 milliseconds; P=.24) among perfusion grades 0, 1, 2, and 3, respectively. Similar results were obtained comparing TIMI grades 0/1 with 2/3 and 0/1/2 with 3. Patients with left anterior descending (versus right and left circumflex) coronary artery occlusion showed significantly greater QTd (70±29 versus 59±27 milliseconds, P=.003) and JTd (74±30 versus 63±27 milliseconds, P=.004). Similarly, patients with anterior (versus inferior/lateral) AMI showed significantly greater QTd (69±30 versus 59±27 milliseconds, P=.006) and JTd (73 ±30 versus 63±27 milliseconds, P=.007). Results did not change when Bazett's QT, or JT, was substituted for QT or JT or when ANOVA included adjustments for age, sex, drug assignment, infarct site, infarct vessel, and number of measurable leads. On ANCOVA, the relation of QTd or JTd and perfusion grade was not influenced by heart rate.
Conclusions Successful thrombolysis is associated with less QTd and JTd in post-AMI patients. The results are equally significant when either QT or JT is used for analysis. These data support the hypothesis that QTd after AMI depends on reperfusion status as well as infarct site and size. Reduction in QTd and its corresponding risk of ventricular arrhythmia may be mechanisms of benefit of thrombolytic therapy. (Circulation. 1994;90:94-100.)
Key Words * QT dispersion * electrocardiography a thrombolysis * infarction * intervals C linical and experimental data have shown that prolongation of the QT interval measured from the standard 12-lead ECG is a risk factor for ventricular arrhythmia and sudden death in patients with1-5 and those without6-9 previous acute myocardial infarction (AMI). The Rotterdam QT project8 showed that QT, prolongation is a risk factor for sudden death independent of age, history of AMI, heart rate, and drug use. There is further strong support for the hypothesis that interlead variations in QT interval reflect regional variations in ventricular repolarization,10-13 and increased dispersion of ventricular recovery time is believed to provide a substrate that supports serious ventricular arrhythmias.14-20 Previous work has indeed suggested that QT dispersion is significantly greater in patients with arrhythmias than in comparable patients without such events. [17] [18] [19] Thrombolytic therapy, on the other hand, has become the cornerstone of treatment for AMI. It is now indisputable that treatment of AMI with a thrombolytic agent improves survival and preserves myocardial function.2'-27 Successfully reperfused patients have demonstrated a lower incidence of early and late mortality, as well as a higher left ventricular ejection fraction (with early therapy), compared with conventionally treated patients. Studies have also indicated that in-hospital and long-term benefits of thrombolysis are closely related to early reestablishment and maintenance of coronary blood flow. 22, 28, 29 In addition to effects on mechanical function, effects of reperfusion therapy on electrical stability are of interest. The present study was undertaken to assess the effect of successful thrombolytic therapy on QT dispersion in patients after AMI and to evaluate the possible prognostic value of QT dispersion in such patients. ANCOVA was also used to assess whether the relation of QT or JT dispersion and perfusion grade was influenced by heart rate. Spearman's rank correlation procedure was done to determine the correlation of QT or JT dispersion with peak cardiac enzymes, total lactic dehydrogenase (LDH), and LDH isoenzyme-1 (LDH-1). Last, ANOVA using factorial design was performed to determine the most important predictors of differences in QT or JT dispersion after AMI.
Results

Patient Demographics
Of the 370 patients enrolled in TEAM-2, 126 patients were excluded because of the following reasons: no discharge ECG (n=65), poor-quality ECG (n=29), unavailable records (n=11), no angiographic scoring done (n=8), and the presence of bundle branch block (n=9), atrioventricular block (n= 2), or atrial fibrillation (n=2). The 
Angiographic Analysis
All 244 patients had coronary angiograms done at 2.4±0.9 hours (range, 0.6 to 6.5 hours) after thrombolytic therapy. The infarct lesion was identified within the right coronary artery in 111 patients (46%), the left anterior descending coronary artery in 104 patients (43%), and the left circumflex coronary artery in 27 patients (11%). Two patients had normal coronaries and were assigned a TIMI perfusion grade of 3.
TIMI perfusion grades 0, 1, 2, and 3 were achieved in 41 (17%), 19 (8%), 35 (14%), and 149 (61%) patients, respectively. There was no difference in the distribution of perfusion grades between patients treated with streptokinase and anistreplase (Fig 1) The main goal of thrombolytic therapy in patients with AMI is the establishment and maintenance of coronary patency to improve left ventricular function and decrease mortality. Although the use of thrombolytic agents has been documented to reduce mortality rates after infarction, the mechanisms of this benefit continue to be debated, potentially including improvements in both mechanical and electrical functions. However, studies have shown that postinfarction patients with open arteries have a lower mortality rate than patients with closed arteries. Mortality rates as low as 2.5% have been reported in patients with patent arteries compared with 15% in patients with closed arteries.37 Mechanisms proposed to account for the beneficial effects of early and late reperfusion on mortality have been reviewed. 38 Our study demonstrates a favorable consequence of reperfusion distinct from reduction in infarct size or improvement in myocardial function. Our results suggest that successfully reperfused patients (ie, those with TIMI grade 2/3) exhibit a more stable electrical substrate than do those with persistent occlusion. Achievement of early patency might correlate with a reduced incidence of subsequent arrhythmic or cardiac death.
Considering that post-AMI patients are generally at increased risk for arrhythmic death, reduction in QT or JT dispersion, a marker of dispersion of ventricular repolarization, in these patients by reperfusion could have important clinical implications. Accordingly, the assessment of QT or JT dispersion at discharge could be prognostically useful.
There are many reports in the literature relating the risk of subsequently developing serious ventricular arrhythmias (eg, ventricular tachycardia) with the perfusion status of the infarct artery in patients after AMI.39-41 An increased frequency of late potentials on signal-averaged ECG has also been demonstrated after AMI in patients with occluded compared with perfused infarct-related arteries in some but not other studies.42-44 However, the unique contribution of this study is the demonstration that a strong correlation exists between the early perfusion status of the infarct-related artery after thrombolysis and the degree of dispersion of ventricular repolarization times. Other investigators have proposed the hypothesis that afterdepolarizations are the basis for the long QT syndrome.51 This hypothesis links clinical observations with cellular electrophysiological phenomena that suggest that these afterdepolarizations are the basis for the U wave on the ECG and that triggered activity is responsible for initiation of the associated arrhythmias. Although there is growing interest in the afterpotential hypothesis, studies to evaluate this theory in the postinfarction setting have not been reported.
QT Dispersion in Healthy Subjects
Previous studies have shown that healthy subjects exhibit a small degree of QT dispersion.11"246 These studies have also shown that interobserver differences in QT measurement are small compared with the typical values for QT dispersion observed in patients with myocardial infarction. In our study, the QT dispersion noted in patients with patent arteries (54+20 milliseconds) was in the same range established for healthy subjects in the studies of Sylven et al (54±+27 milliseconds),46 Mirvis (59±12.9 milliseconds)," and Cowan et al (48±18 milliseconds).12 In contrast, patients in our study who had nonpatent coronary arteries showed a substantially greater and statistically significantly increased QT dispersion (94±29 milliseconds). These indicate that true increases in QT dispersion (presumed to be due to regional differences in repolarization) can be differentiated from normal, physiologically occurring interlead variations and those due to technical artifacts (ie, caused by differences in unipolar versus bipolar leads, differential tissue attenuation or cancellation of vectors, etc). Because homogeneity of recovery time is believed to protect against arrhythmias and dispersion of recovery time is believed to be arrhythmogenic, the reduction in QT and JT dispersion seen in our reperfused patients may be interpreted as evidence for this mechanism of benefit of thrombolytic therapy. 10) were evaluable. The difference in QT interval variation in measured leads between patients with patent and nonpatent arteries was not explained by a difference in the number of or distribution of leads contributing to QT dispersion determination. Thus, with the use of a reliable computerized measurement system, the QT interval was able to be accurately assessed in the majority of leads, and a reliable measure of QT dispersion could be determined.
There is no universally recognized standard method of analysis or of lead selection for QT interval assessment. Cowan et a112 found divergent estimates of QT interval among methods and underscored the need for standardization of lead selection. Some investigators have used only the precordial V, through V6 leads20 in the selection of maximal and minimal QT intervals. In the present study, all leads that were technically adequate were measured, negating the concern about whether the "best" leads or lead groups were chosen for measurement.
Bazett's formula for calculation of QT. has been found to give suboptimal correction, as it includes a slight overcorrection of the QT interval for fast heart rates. 35 However, none of the other proposed methods of rate correction for QT have been generally accepted. In view of potential errors that may be generated by suboptimal correction of the QT interval for heart rate, it has been suggested that including the uncorrected QT interval and heart rate as well as QT. data in published reports would be helpful to reader interpretation. In our study, results were reported for both uncorrected and heart rate-corrected intervals and were consistent whether QT or QTc measurements were used in the analysis, strengthening the validity of the relation between QT dispersion and perfusion status noted.
Finally, the study was limited by the absence of long-term outcome information, which was not collected in TEAM-2. Other studies are needed to verify the predicted better clinical outcome of patients with reduced QTd after thrombolysis. Conclusions The results of the present study show that successful thrombolysis is associated with less QT and JT dispersion on the convalescent (predischarge) ECG in patients after AMI. The results were equally significant whether QT or JT was used in the analysis. Our data support the hypothesis that QT dispersion after myocardial infarction depends on reperfusion status, infarct site, and infarct size. Reduction in QT dispersion may be a mechanism of benefit of thrombolytic therapy.
